MoneyWorks4Me

Concord Drugs informs about closure of trading window

28 Mar 2023 Evaluate
Concord Drugs has informed that the trading window for dealing in the securities of the Company will remain closed from 01st April, 2023 till 48 hours after the declaration of financial results for the quarter and financial year ended 31.03.2023, for all designated persons, their immediate relatives and all connected persons covered under the Company’s Code of Conduct. 

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..